Biocon Shares Down As Firm Withdraws EU Approval Of Two Drugs Business Business / Business 7 years ago 341 Views comments European drug regulators informed Biocon that the manufacturing facilities for two drugs needed to be re-inspected. Read more
Business Share Bazaar : Markets ignored geo-political tensions, says expert Business / Business - 7 years ago
Business Commodity Headlines : Recovery in Crude prices | क्रूड क़ीमतों में रिकवरी Business / Business - 7 years ago
Business GoM recommends to make common slab 1% in composition scheme Business / Business - 7 years ago
Business ONGC to buy 51% stake in HPCL, cabinet approves selling | ONGC-HPCL मर्जर मंज़ूर: सूत्र Business / Business - 7 years ago
Comments